Maternal one-carbon metabolism, MTHFR and TCN2 genotypes and neural tube defects in India

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 9, 2011, Pages 848-856

  Godbole, Koumudi ^a   Gayathri, Panjalingam ^b   Ghule, Smita ^a   Sasirekha, Batchu Venkatanaga ^b   Kanitkar Damle, Amruta ^a   Memane, Nilam ^a   Suresh, Seshadri ^c   Sheth, Jayesh ^d   Chandak, Giriraj Ratan ^b   Yajnik, Chittaranjan S ^a  

^a KEM HOSPITAL   (India)

^b CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^c Fetal Care Research Foundation   (India)

^d FRIGE Foundation for Research in Genetics and Endocrinology   (India)

Author keywords

Gene nutrient interaction; Holo transcobalamin; Homocysteine; MTHFR polymorphisms; Neural tube defects; One carbon metabolism; Predictive risk; TCN2 polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; HOMOCYSTEINE; TRANSCOBALAMIN; TRANSCOBALAMIN II;

ADULT; ARTICLE; CARBON METABOLISM; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC MARKER; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL NUTRITION; NEURAL TUBE DEFECT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGENY;

ADULT; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; INDIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCOBALAMINS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 80052580390     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20841     Document Type: Article

References (54)

1. Afman LA, van der Put NM, Thomas CM, et al. 2001. Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects. Quant J Med 94: 159-166.
2. Bamonti F, Moscato GA, Novembrino C, et al. 2010. Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the laboratory. Clin Chem Lab Med 48: 249-253.
3. Beaudin AE, Stover PJ. 2007. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res C Embryo Today 81: 183-203.
4. Behunova J, Klimcakova L, Zavadilikova E, et al. 2010. Methylenetetrahydrofolate reductase gene polymorphisms and neural tube defects epidemiology in the Slovak population. Birth Defects Res A Clin Mol Teratol 88: 695-700.
5. Blom HJ, Shaw GM, den Heijer M, Finnell RH. 2006. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7: 724-731.
6. Botto LD, Yang Q. 2000. 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151: 862-877.
7. Brady J, Wilson L, McGregor L, et al. 2008. Active B12: a rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer. Clin Chem 54: 567-573.
8. Bufalino A, Ribeiro Paranaíba LM, Nascimento de Aquino S, et al. 2010. Maternal polymorphisms in folic acid metabolic genes are associated with nonsyndromic cleft lip and/or palate in the Brazilian population. Birth Defects Res A Clin Mol Teratol 88: 980-986.
9. Candito M, Rivet R, Herbeth B, et al. 2008. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet A 146A: 1128-1133.
10. Centers for Disease Control and Prevention (CDC). 2004. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 53: 362-365.
11. Central Technical Co-coordinating Unit, Indian Council of Medical Research. 2000. Multicentric study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects in India. Indian J Med Res 112: 206-211.
12. Cherian A, Seena S, Bullock RK, Antony AC. 2005. Incidence of neural tube defects in the least-developed area of India: a population-based study. Lancet 366: 930-931.
13. Clarke R, Grimley Evans J, Schneede J, et al. 2004. Vitamin B12 and folate deficiency in later life. Age Ageing 33: 34-41.
14. Czeizel AE, Dudás I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Eng J Med 327: 1832-1835.
15. Félix TM, Leistner S, Giugliani R. 2004. Metabolic effects and the methylenetetrahydrofolate reductase (MTHFR) polymorphism associated with neural tube defects in southern Brazil. Birth Defects Res A Clin Mol Teratol 70: 459-463.
16. Gardiki-Kouidou P, Seller MJ. 1988. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin Genet 33: 441-448.
17. Godbole K, Deshmukh U, Yajnik CS. 2009. Nutrigenetic determinants of neural tube defects in India. Indian Pediatr 46: 467-475.
18. González-Herrera L, García-Escalante G, Castillo-Zapata I, et al. 2002. Frequency of the thermolabile variant C677T in the MTHFR gene and lack of association with neural tube defects in the State of Yucatan, Mexico. Clin Genet 62: 394-398.
19. Hazra A, Kraft P, Lazarus R, et al. 2009. Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway. Hum Mol Genet 18: 4677-4687.
20. Horne DW, Patterson D. 1988. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem 34: 2357-2359.
21. Jacques PF, Bostom AG, Williams RR, et al. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93: 7-9.
22. Katre P, Bhat D, Lubree H, et al. 2010. Vitamin B12 and folic acid supplementation and plasma total homocysteine concentrations in pregnant Indian women with low B12 and high folate status. Asia Pac J Clin Nutr 19: 335-343.
23. Kelleher BP, Walshe KG, Scott JM, O'Broin SD. 1987. Microbiological assay for vitamin B12 with use of a colistin-sulfate-resistant organism. Clin Chem 33: 52-54.
24. Kirke PN, Molloy AM, Daly LE, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86: 703-708.
25. Kluijtmans LA, Young IS, Boreham CA, et al. 2003. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101: 2483-2488.
26. Koch MC, Stegmann K, Ziegler A, et al. 1998. Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population. Eur J Pediatr 157: 487-492.
27. Kulkarni ML, Mathew MA, Ramachandran B. 1987. High incidence of neural-tube defects in South India. Lancet 1: 1260.
28. Lucock M, Daskalakis I, Briggs D, et al. 2000. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677C -> t methylenetetrahydrofolate reductase and 2756A-> g methionine synthase genotypes. Mol Genet Metab 70: 27-44.
29. Martínez de Villarreal LE, Delgado-Enciso I, Valdéz-Leal R, et al. 2001. Folate levels and N(5), N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study. Arch Med Res 32: 277-282.
30. Molloy AM, Kirke PN, Troendle JF, et al. 2009. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 123: 917-923.
31. Morkbak AL, Hvas AM, Milman N, Nexo E. 2007. Holotranscobalamin remains unchanged during pregnancy. Longitudinal changes of cobalamins and their binding proteins during pregnancy and postpartum. Haematologica 92: 1711-1712.
32. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
33. Muthayya S, Kurpad AV, Duggan CP, et al. 2006. Low maternal vitamin B12 status is associated with intrauterine growth retardation in urban South Indians. Eur J Clin Nutr 60: 791-801.
34. Namour F, Olivier J, Abdelmouttaleh I, et al. 2001. Transcobalamin codon 259 polymorphism in HT-29 and Caco-2 cells and in Caucasians: relation to transcobalamin and homocysteine concentration in blood. Blood 97: 1092-1098.
35. Obeid R, Morkbak AL, Munz W, et al. 2006. The cobalamin-binding proteins transcobalamin and haptocorrin in maternal and cord blood sera at birth. Clin Chem 52: 263-269.
36. O'Leary VB, Mills JL, Parle-McDermott A, et al. 2005. Screening for new MTHFR polymorphisms and NTD risk. Am J Med Genet A 138A: 99-106.
37. Ou CY, Stevenson RE, Brown VK, et al. 1996. 5, 10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects. Am J Med Genet 63: 610-614.
38. Parle-McDermott A, Mills JL, Kirke PN, et al. 2003. Analysis of the MTHFR 1298A->C and 677C->T polymorphisms as risk factors for neural tube defects. J Hum Genet 48: 190-193.
39. Ray JG, Wyatt PR, Thompson MD, et al. 2007. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology 18: 362-366.
40. Refsum H, Yajnik CS, Gadkari M, et al. 2001. Hyperhomocysteinemia and elevated methylmalonic acid indicate a high prevalence of cobalamin deficiency in Asian Indians. Am J Clin Nutr 74: 233-241.
41. Refsum H, Smith AD, Ueland PM, et al. 2004. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50: 3-32.
42. Relton CL, Wilding CS, Laffling AJ, et al. 2004. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81: 273-281.
43. Steen MT, Bodde AJ, Fisher AJ, et al. 1998. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid. Prenatal Diagn 18: 545-555.
44. Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. 1994. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43: 1475-1480.
45. Suarez L, Hendricks K, Felkner M, Gunter E. 2003. Maternal serum B12 levels and risk for neural tube defects in a Texas-Mexico border population. Ann Epidemiol 13: 81-88.
46. Ubbink JB. 1999. Metabolic markers of vitamin nutritional status. Am J Clin Nutr 70: 789-790.
47. van der Put NM, Steegers-Theunissen RP, Frosst P, et al. 1995. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 1070-1071.
48. van der Put NM, Eskes TK, Blom HJ. 1997. Is the common 677C->T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. Quant J Med 90: 111-115.
49. van der Put NM, Gabreëls F, Stevens EM, et al. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051.
50. Verma IC. 1978. High frequency of neural-tube defects in North India. Lancet 1: 879-880.
51. Volcik KA, Blanton SH, Tyerman GH, et al. 2000. Methylenetetrahydrofolate reductase and spina bifida: evaluation of level of defect and maternal genotypic risk in Hispanics. Am J Med Genet 95: 21-27.
52. Whitehead AS, Gallagher P, Mills JL, et al. 1995. A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. Quant J Med 88: 763-766.
53. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33-39.
54. Yajnik CS, Deshpande SS, Jackson AA, et al. 2008. Vitamin B(12) and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51: 29-38.